Wo NC - Search Results

1

An investigation of position 3 in arginine vasopressin with aliphatic, aromatic, conformationally-restricted, polar and charged amino acids.

Stoev S, Cheng LL, Olma A, Klis WA, Manning M, Sawyer WH, Wo NC, Chan WY. Stoev S, et al. Among authors: wo nc. J Pept Sci. 1999 Mar;5(3):141-53. doi: 10.1002/(SICI)1099-1387(199903)5:3<141::AID-PSC180>3.0.CO;2-6. J Pept Sci. 1999. PMID: 10323558

2

Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity.

Guillon G, Pena A, Murat B, Derick S, Trueba M, Ventura MA, Szeto HH, Wo N, Stoev S, Cheng LL, Manning M. Guillon G, et al. J Pept Sci. 2006 Mar;12(3):190-8. doi: 10.1002/psc.710. J Pept Sci. 2006. PMID: 16130178

3

Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban.

Manning M, Cheng LL, Stoev S, Wo NC, Chan WY, Szeto HH, Durroux T, Mouillac B, Barberis C. Manning M, et al. Among authors: wo nc. J Pept Sci. 2005 Oct;11(10):593-608. doi: 10.1002/psc.667. J Pept Sci. 2005. PMID: 15880385

4

Design and synthesis of potent, highly selective vasopressin hypotensive agonists.

Stoev S, Cheng LL, Manning M, Wo NC, Szeto HH. Stoev S, et al. Among authors: wo nc. J Pept Sci. 2006 Sep;12(9):592-604. doi: 10.1002/psc.756. J Pept Sci. 2006. PMID: 16625682

5

Potent V2/V1a vasopressin antagonists with C-terminal ethylenediamine-linked retro-amino acids.

Manning M, Przybylski J, Grzonka Z, Nawrocka E, Lammek B, Misicka A, Cheng LL, Chan WY, Wo NC, Sawyer WH. Manning M, et al. Among authors: wo nc. J Med Chem. 1992 Oct 16;35(21):3895-904. doi: 10.1021/jm00099a018. J Med Chem. 1992. PMID: 1433200

6

Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine-vasopressin.

Manning M, Stoev S, Bankowski K, Misicka A, Lammek B, Wo NC, Sawyer WH. Manning M, et al. Among authors: wo nc. J Med Chem. 1992 Jan 24;35(2):382-8. doi: 10.1021/jm00080a027. J Med Chem. 1992. PMID: 1531076

7

Design of potent and selective linear antagonists of vasopressor (V1-receptor) responses to vasopressin.

Manning M, Stoev S, Kolodziejczyk A, Klis WA, Kruszynski M, Misicka A, Olma A, Wo NC, Sawyer WH. Manning M, et al. Among authors: wo nc. J Med Chem. 1990 Nov;33(11):3079-86. doi: 10.1021/jm00173a027. J Med Chem. 1990. PMID: 2231609

8

No requirements of cyclic conformation of antagonists in binding to vasopressin receptors.

Manning M, Przybylski JP, Olma A, Klis WA, Kruszynski M, Wo NC, Pelton GH, Sawyer WH. Manning M, et al. Among authors: wo nc. Nature. 1987 Oct 29-Nov 4;329(6142):839-40. doi: 10.1038/329839a0. Nature. 1987. PMID: 2959865

9

Novel linear antagonists of the antidiuretic (V2) and vasopressor (V1) responses to vasopressin.

Manning M, Klis WA, Kruszynski M, Przybylski JP, Olma A, Wo NC, Pelton GH, Sawyer WH. Manning M, et al. Among authors: wo nc. Int J Pept Protein Res. 1988 Dec;32(6):455-67. doi: 10.1111/j.1399-3011.1988.tb01376.x. Int J Pept Protein Res. 1988. PMID: 3246475

10

Effects of a D-Cys6/L-Cys6 interchange in nonselective and selective vasopressin and oxytocin antagonists.

Manning M, Cheng LL, Klis WA, Balaspiri L, Olma A, Sawyer WH, Wo NC, Chan WY. Manning M, et al. Among authors: wo nc. J Med Chem. 1995 May 12;38(10):1762-9. doi: 10.1021/jm00010a020. J Med Chem. 1995. PMID: 7752199

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters